Source: Institutional Research Information System (IRIS)
Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna, ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, «TRANSLATIONAL LUNG CANCER RESEARCH», 2022, 11, pp. 2216 - 2229 [Scientific article] Open Access
Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinelli G.; Fabbri F.; Gallerani G., Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis, «CANCERS», 2022, 14, pp. 1 - 16 [Scientific article] Open Access
Rossi T.; Angeli D.; Martinelli G.; Fabbri F.; Gallerani G., From phenotypical investigation to RNA-sequencing for gene expression analysis: A workflow for single and pooled rare cells, «FRONTIERS IN GENETICS», 2022, 13, pp. 1 - 10 [Scientific article] Open Access
Sabbatinelli J.; Giuliani A.; Matacchione G.; Latini S.; Laprovitera N.; Pomponio G.; Ferrarini A.; Svegliati Baroni S.; Pavani M.; Moretti M.; Gabrielli A.; Procopio A.D.; Ferracin M.; Bonafè M.; Olivieri F., Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients, «MECHANISMS OF AGEING AND DEVELOPMENT», 2021, 193, pp. 1 - 6 [Scientific article]
Laprovitera N.; Riefolo M.; Ambrosini E.; Klec C.; Pichler M.; Ferracin M., Cancer of unknown primary: Challenges and progress in clinical management, «CANCERS», 2021, 13, pp. 1 - 29 [Scientific article] Open Access
Laprovitera N.; Salamon I.; Gelsomino F.; Porcellini E.; Riefolo M.; Garonzi M.; Tononi P.; Valente S.; Sabbioni S.; Fontana F.; Manaresi N.; D'Errico A.; Pantaleo M.A.; Ardizzoni A.; Ferracin M., Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches, «FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY», 2021, 9, pp. 1 - 15 [Scientific article] Open Access
Manganelli M.; Grossi I.; Ferracin M.; Guerriero P.; Negrini M.; Ghidini M.; Senti C.; Ratti M.; Pizzo C.; Passalacqua R.; Molfino S.; Baiocchi G.; Portolani N.; Marchina E.; De Petro G.; Salvi A., Longitudinal circulating levels of mir-23b-3p, mir-126-3p and lncrna gas5 in hcc patients treated with sorafenib, «BIOMEDICINES», 2021, 9, pp. 1 - 12 [Scientific article] Open Access
Dika E.; Broseghini E.; Porcellini E.; Lambertini M.; Riefolo M.; Durante G.; Loher P.; Roncarati R.; Bassi C.; Misciali C.; Negrini M.; Rigoutsos I.; Londin E.; Patrizi A.; Ferracin M., Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis, «CELL DEATH & DISEASE», 2021, 12, pp. 1 - 15 [Scientific article] Open Access
Pilli T.; Cardinale S.; Cantara S.; Dalmazio G.; Forleo R.; Capezzone M.; Bassi C.; Negrini M.; Ferracin M.; Castagna M.G., Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone, «ENDOCRINE», 2021, 73, pp. 177 - 185 [Scientific article]
Laprovitera N.; Riefolo M.; Porcellini E.; Durante G.; Garajova I.; Vasuri F.; Aigelsreiter A.; Dandachi N.; Benvenuto G.; Agostinis F.; Sabbioni S.; Berindan Neagoe I.; Romualdi C.; Ardizzoni A.; Trere' D.; Pichler M.; D'Errico A.; Ferracin M., MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary, «MOLECULAR ONCOLOGY», 2021, 15, pp. 2732 - 2751 [Scientific article] Open Access